Gene · 4175
Papers2,153
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,153
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical assessment for diet prescription. | J Prev Med Hyg | 2022 | 36479490 | PubTator, text mining | PubMed |
| Polymorphisms, diet and nutrigenomics. | J Prev Med Hyg | 2022 | 36479483 | PubTator, text mining | PubMed |
| Construction and validation of prognostic signature for hepatocellular carcinoma basing on hepatitis B virus related specific genes. | Infect Agent Cancer | 2022 | 36474267 | PubTator, text mining | PubMed |
| Comprehensive Pan-Cancer Analysis of GINS2 for Human Tumour Prognosis and as an Immunological Biomarker. | Comput Math Methods Med | 2022 | 36466552 | PubTator, text mining | PubMed |
| MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma. | Front Oncol | 2022 | 36465369 | PubTator, text mining | PubMed |
| The identification and preliminary study of lncRNA TUG1 and its related genes in hepatocellular carcinoma. | Arch Med Sci | 2022 | 36457956 | PubTator, text mining | PubMed |
| Glycemic control releases regenerative potential of pancreatic beta cells blocked by severe hyperglycemia. | Cell Rep | 2022 | 36450253 | PubTator, text mining | PubMed |
| Pathway-level mutation analysis in primary high-grade serous ovarian cancer and matched brain metastases. | Sci Rep | 2022 | 36446793 | PubTator, text mining | PubMed |
| Minichromosome maintenance gene family: potential therapeutic targets and prognostic biomarkers for lung squamous cell carcinoma. | Aging (Albany NY) | 2022 | 36445337 | PubTator, text mining | PubMed |
| Research on application of tumor treating fields in glioblastoma: A bibliometric and visual analysis. | Front Oncol | 2022 | 36439464 | PubTator, text mining | PubMed |
| Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma. | J Hematol Oncol | 2022 | 36434634 | PubTator, text mining | PubMed |
| Solanum tuberosum Microtuber Development under Darkness Unveiled through RNAseq Transcriptomic Analysis. | Int J Mol Sci | 2022 | 36430314 | PubTator, text mining | PubMed |
| Signatures of Breast Cancer Progression in the Blood: What Could Be Learned from Circulating Tumor Cell Transcriptomes. | Cancers (Basel) | 2022 | 36428760 | PubTator, text mining | PubMed |
| Exploration of blood-derived coding and non-coding RNA diagnostic immunological panels for COVID-19 through a co-expressed-based machine learning procedure. | Front Immunol | 2022 | 36405703 | PubTator, text mining | PubMed |
| Development and validation of a prognostic risk signature for lung adenocarcinoma constructed by six ferroptosis, necroptosis, and pyroptosis-related lncRNAs. | J Thorac Dis | 2022 | 36389299 | PubTator, text mining | PubMed |
| Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation. | Nat Commun | 2022 | 36376293 | PubTator, text mining | PubMed |
| Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma. | BMC Gastroenterol | 2022 | 36371178 | PubTator, text mining | PubMed |
| Breast Cancer Cells Reprogram the Oncogenic lncRNAs/mRNAs Coexpression Networks in Three-Dimensional Microenvironment. | Cells | 2022 | 36359853 | PubTator, text mining | PubMed |
| Exploiting DNA Replication Stress as a Therapeutic Strategy for Breast Cancer. | Biomedicines | 2022 | 36359297 | PubTator, text mining | PubMed |
| Processes in DNA damage response from a whole-cell multi-omics perspective. | iScience | 2022 | 36339253 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4175/papers?page=15